Nuclear prostaglandin signaling system: Biogenesis and actions via heptahelical receptors

Canadian Journal of Physiology and Pharmacology

Volumn 81, Issue 2, 2003, Pages 196-204

  Gobeil Jr , Fernand ^a   Vazquez Tello, Alejandro ^b   Marilise Marrache, Anne ^b,c   Bhattacharya, Mosumi ^b   Checchin, Daniella ^b,c   Bkaily, Ghassan ^a   Lachapelle, Pierre ^c   Ribeiro Da Silva, Alfredo ^c   Chemtob, Sylvain ^b,c  

^a UNIVERSITÉ DE SHERBROOKE   (Canada)

^b UNIVERSITY OF MONTREAL   (Canada)

^c MCGILL UNIVERSITY   (Canada)

Author keywords

Cell nucleus; EP receptors; Gene transcription; PGE2; Signal transduction

Indexed keywords

CELL SURFACE PROTEIN; G PROTEIN COUPLED RECEPTOR; NITRIC OXIDE SYNTHASE; PROSTAGLANDIN; PROSTAGLANDIN E RECEPTOR; PROSTAGLANDIN E2; PROSTAGLANDIN RECEPTOR; RNA;

BIOGENESIS; BRAIN BLOOD VESSEL; CARDIOVASCULAR SYSTEM; CELL COMPARTMENTALIZATION; CELL NUCLEUS; CELL PROLIFERATION; CELL SURFACE; CELLULAR DISTRIBUTION; CONFERENCE PAPER; ENDOTHELIUM CELL; GENE CONTROL; GENE EXPRESSION; HOMEOSTASIS; INFLAMMATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN INTERACTION; REPRODUCTION; SIGNAL TRANSDUCTION;

EID: 0037304634     PISSN: 00084212     EISSN: None     Source Type: Journal    
DOI: 10.1139/y02-163     Document Type: Conference Paper

References (97)

1. Abramovitz, M., Adam, M., Bole, Y., Carriere, M., Denis, D., Godbout, C., Lamontagne, S., Rochette, C., Sawyer, N., Tremblay, N.M., Belley, M., Gallant, M., Dufresne, C., Gareau. Y, Ruel, R., Juteau, H., Labelle, M., Ouimet, N., and Metters, K.M. 2000. The utilization of recombinant prostanoid receptors to determine the affinities and selectivities of prostaglandins and related analogs. Biochim. Biophys. Acta 1483: 285-293.
2. Allard, W.J., Sigal, I.S., and Dixon, R.A. 1987. Sequence of the gene encoding the human M1 muscarinic acetylcholine receptor. Nucleic Acids Res. 15: 10 604.
3. 2s in fatty acid release in the cell death pathway. J. Biol. Chem. 275: 18248-18258.
4. Balboa, M.A., and Insel, P.A. 1995. Nuclear phospholipase D in Madin-Darby canine kidney cells. J. Biol. Chem. 50: 29843-29847.
5. Barsony, J., and Marx, S. 1990. Immunocytology on microwave-fixed cells reveals rapid and agonist-specific changes in subcellular accumulation patterns for cAMP or cGMP. Proc. Natl. Acad. Sci. U.S.A. 87: 1188-1192.
6. Beaudet, A., Nouel, D., Stroh, T., Vandenbulcke, F., Dal-Farra, C., and Vincent, J.P. 1998. Fluorescent ligands for studying neuropeptide receptors by confocal microscopy. Braz. J. Med. Biol. Res. 31: 1479-1489.
7. 2 receptors. Proc. Natl. Acad. Sci. U.S.A. 95: 15 792 - 15 797.
8. 4 in the nuclear envelope. J. Biol. Chem. 274: 15 719 - 15 792.
9. Bhattacharya, M., Varma, D.R., and Chemtob, S. 1999b. Nuclear prostaglandin receptors. Gene Ther. Mol. Biol. 4: 323-338.
10. Bito, L.Z., and Baroody, R.A. 1975. Inhibition of pulmonary prostaglandin metabolism by inhibitors of prostaglandin biotransport (probenecid and bromcresol green). Prostaglandins, 10: 633-639.
11. 2 receptor subtypes. Eur. J. Pharmacol. 340: 227-241.
12. Bonner, T.L., Young, A.C., Brann, M.R., and Buckley, N.J. 1988. Cloning and expression of the human and rat m5 muscarinic acetylcholine receptor genes. Neuron, 1: 403-410.
13. Buchner, K. 1995. Protein kinase C in the transduction of signals toward and within the cell nucleus. Eur. J. Biochem. 228: 211-221.
14. Campbell, W.B., and Halushka, P.V. 1996. Lipid-derived autocoids: eicosanoids and platelet activating factor. In The pharmacological basis of therapeutics. 9th ed. Edited by A.G. Gileman, T.W. Rall, A.S. Nies, P. Taylor. Pergamon Press, New York. pp. 601-614.
15. Castel, M.N., Woulfe, J., Wang, X., Laduron, P.M., and Beaudet, A. 1992. Light and electron microscopic localization of retrogradely transported neurotensin in rat nigrostriatal dopaminergic neurons. Neuroscience, 50: 269-282.
16. Chase, P.B., Halonen, M., and Regan, J.W. 1993. Cloning of a human platelet-activating factor receptor gene: evidence for an intron in the 5′-untranslated region. Am. J. Respir. Cell Mol. Biol. 8: 240-244.
17. Chemtob, S., Li, D.Y., Abran, D., Hardy, P., Peri, K.G., and Varma, D.R. 1996. The role of prostaglandin receptors in regulating cerebral blood flow in the perinatal period. Acta Paediatrica 85: 517-524.
18. Chen, R., Mukhin, Y.V., Garnovskaya, M.N., Thielen, T.E., Iijima, Y., Huang, C., Raymond, J.R., Ullian, M.E., and Paul, R.V. 2000. A functional angiotensin II receptor-GFP fusion protein: evidence for agonist-dependent nuclear translocation. Am. J. Physiol. 279: F440-F448.
19. Cheng, M., Boulton, T.G., and Cobb, M.H. 1996. Erk 3 is a constitutively nuclear protein kinase. J. Biol. Chem. 271: 8951-8958.
20. Christophe, D., Christophe-Hobertus, C., and Pichon, B. 2000. Nuclear targeting of proteins: how many different signals. Cellular Signaling, 12: 337-341.
21. Chun, J., Contos, J.J.A., and Munroe, D. 1999. A growing family of receptor genes for lysophosphatidic acid (LPA) and other lysophospholipids. Cell Biochem. Biophys. 30: 213-241.
22. Cieslik, K., Abrams, C.S., and Wu, K.K. 2001. Up-regulation of endothelial nitric-oxide synthase promoter by the phosphatidylinositol 3-kinase gamma /Janus kinase 2/MEK-1-dependent pathway. J. Biol. Chem. 276: 1211-1219.
23. Cocco, L., Rubbini, S., Manzoli, L., Billi, A.M., Peruzzi, D., Matteucci, A., Artico, M., Gilmour, R.S., and Rhee, S.G. 1999. Inositides in the nucleus: presence and characterization of the isozymes of phospholipase C beta family in NIH 3T3 cells. Biochim. Biophys. Acta, 1438: 295-299.
24. Coleman, R.A., Smith, W.L., and Narumiya, S. 1994. International Union of Pharmacology. Classification of prostanoid receptors: properties, distribution, and structure of the receptors and their subtypes. Pharmacol. Rev. 46: 205-229.
25. 2 and activation of protein kinase C. J. Biol. Chem. 269: 27 258 - 27 263.
26. Delfino, F., and Walker, W.H. 1998. Stage-specific nuclear expression of NF-kappaB in mammalian testis. Mol. Endocrinol. 12: 1696-1707.
27. Divecha, N., and Irvine, R.F. 1995. Phospholipid signaling. Cell, 80: 269-278.
28. D'Santos, C.S., Clarke, J.H., and Divecha, N. 1998. Phospholipid signaling in the nucleus. Biochim. Biophys. Acta, 1436: 201-232.
29. 2. J. Pharmacol. Exp. Ther. 291: 627-633.
30. Faure, M.P., Alonso, A., Nouel, D., Gaudriault, G., Dennis, M., Vincent, J.P., and Beaudet, A. 1995. Somatodendritic internalization and perinuclear targeting of neurotensin in the mammalian brain. J. Neurosci. 15: 4140-4147.
31. 2 receptor in mammary tumor metastasis. Cancer. Res. 51: 2047-2050.
32. Funk, C.D. 2001. Prostaglandins and leukotrienes: advances in eicosanoid biology. Science (Washingon, D.C.), 294: 1871-1875.
33. 1 subtype. J. Biol. Chem. 268: 26767 - 26772.
34. Garcia-Garcia, E., Sanchez-Mejorada, G., Rosales, C. 2001. Phosphatidylinositol 3-kinase and ERK are required for NF-κB activation but not for phagocytosis. J. Leukoc. Biol. 70: 649-658.
35. Gashler, A., and Sukhatme, V.P. 1995. Early growth response protein 1(Erg-1): prototype of a zinc-finger family of transcription factors. Prog. Nucleic Acid Res. 50: 191-224.
36. Gerasimenko, O.V., Gerasimenko, J.V., Tepilin, A.V., and Petersen, O.H. 1996. Calcium transport pathways in the nucleus. Eur. J. Physiol. 432: 1-6.
37. Glantschnig, H., Varga, F., and Klaushoffer, K. 1996. The cellular protooncogenes c-fos and erg-1 are regulated by prostacyclin in rodent osteoblasts and fibroblasts. Endocrinology, 137: 4536-4541.
38. 3 receptors. Circ. Res. 90: 682-689.
39. Grady, E.F., Garland, A.M., Gamp, P.D., Lovett, M., Payan, D.G., and Bunnett, N.W. 1995. Delineation of the endocytic pathway of substance P and its seven-transmembrane domain NK1 receptor. Mol. Biol. Cell. 6: 509-524.
40. 3 subtype. Am. J. Physiol. 272: G597-G604.
41. Hertz, R., Berman, I., Keppler, D., and Bar-Tana, J. 1996. Activation of gene transcription by prostacyclin analogues is mediated by peroxisome-activated proliferator receptor (PPAR). J. Biochem. 235: 242-247.
42. 2+ currents in an adrenal cell line. EMBO 7: 613-624.
43. 2+ inflow in hepatocytes. Biochem. J. 248: 911-918.
44. Hunot, S., Brugg, B., Ricard, D., Michel, P.P., Ruberg, M., Faucheux, B.A., Agid, Y., and Hirsch. E.C. 1997. Nuclear translocation of NF-kappaB is increased in dopaminergic neurons of patients with Parkinson disease. Proc. Natl. Acad. Sci. U.S.A. 94: 7531-7536.
45. Kabarowski, J.H.S., Zhu, K., Le, Lu Q., Witte, O.N., and Xu, Y. 2001. Lysophosphatidylcholine as a ligand for the immunoregulatory receptor G2A. Science 293: 702-705.
46. Kanai, N., Lu, R., Satriano, J.A., Bao, Y., Wolkoff, A.W., Schuster, V.L. 1995. Identification and characterization of a prostaglandin transporter. Science 268: 866-869.
47. Kaufmann, W.E., Worley, P.F., Pegg, J., Bremer, M., and Isakson, P. 1996. Cox-2, a synaptically induced enzyme, is expressed by excitatory neurons at postsynaptic sites in rat cerebral cortex. Proc. Natl. Acad. Sci. U.S.A. 93: 2317-2321.
48. Kim, S.J., and Kahn, C.R. 1997. Insulin regulation of mitogenactivated protein kinase kinase (MEK), mitogen-activated protein kinase and casein kinase in the cell nucleus: a possible role in the regulation of gene expression. Biochem. J. 323: 621-627.
49. 2 acts on the perinuclear membranes. J. Biol. Chem. 277: 9358-9365.
50. 2 metabolite binds peroxisome proliferator-activated receptor γ_and promotes adipocyte differentiation. Cell 83: 813-819.
51. Kojima, I., Shibata, H., and Ogata, E. 1986. Pertussis toxin blocks angiotensin II-induced calcium influx but not inositol triphosphate production in adrenal glomerulosa cell. FEBS Lett. 204: 347-351.
52. Kotani, M., Tanaka, I., Ogawa, Y., Usui, T., Tamura, N., Mori, K., Narumiya, S., Yoshimi, T., Nakao, K. 1997. Structural organization of the human prostaglandin EP3 receptor subtype gene. Genomics 40: 425-434.
53. Krisch, B., Feindt, J., and Mentlein, R. 1998. Immunoelectromicroscopic analysis of the ligand-induced internalization of the somatostatin receptor subtype 2 in cultured human glioma cells. J. Histochem. Cytochem. 46: 1233-1242.
54. Leffler, C.W., and Busija, D.W. 1985. Arachidonate metabolism on the cerebral surface of newborn pigs. Prostaglandins 30: 811-817.
55. Leffler, C.W., and Busija, D.W. 1987. Prostanoids and pial arteriolar diameter in hypotensive newborn piglets. Am. J. Physiol. 252: H687-H691.
56. 2α receptor density in brain microvessels of pigs. Br. J. Pharmacol. 112: 59-64.
57. Lin, S.Y., Makino, K., Xia, W., Matin, A., Wen, Y., Kwong, K.Y., Bourguignon, L., and Hung, M.C. 2001. Nuclear localization of EGF receptor and its potential new role as a transcription factor. Nat Cell Biol 3: 802-808.
58. Longin, A.S., Mezin, P., Favier, A., and Verdetti, J. 1997. Presence of zinc and calcium permeant channels in the inner membrane of the nuclear envelope. Biochem. Biophys. Res. Commun. 235: 236-241.
59. Lu, D., Raizada, M.K., and Shaw, G. 1998. Angiotensin II-induced nuclear targeting of the angiotensin type 1 (AT1) receptor in brain neurons. Endocrinology 139: 365-375.
60. Lu, R., Kanai, N., Bao, Y., and Schuster, V.L. 1996. Cloning, in vitro expression, and tissue distribution of a human prostaglandin transporter cDNA (hPGT). J. Clin. Inves. 98: 1142-1149.
61. Malviya, A.N., and Rogue, P.J. 1998. Tell me where is calcium bred: clarifying the roles of nuclear calcium. Cell 92: 17-23.
62. Mazzanti, M., Bustamante, J.O., and Oberleithner, H. 2001. Electrical dimension of the nuclear envelope. Physiol. Rev. 81: 1-19.
63. Marinissen, M.J., and Gutkind, J.S. 2001. G-protein-coupled receptors and signaling networks: emerging paradigms. Trends Pharmacol. Scie. 22: 368-376.
64. 2 regulates inducible nitric oxide synthase in the murine macrophage cell line J774. Prostaglandins 49: 105-115.
65. 2 and by cyclooxygenase inhibitors. Glia 19: 152-160.
66. Minghetti, L., and Levi, G. 1998. Microglia as effector cells in brain damage and repair: focus on prostanoids and nitric oxide. Prog. in Neurobiolog. 54: 99-125.
67. Miyahara, K., Kawamoto, T., Sase, K., Yui, Y., Toda, K., Yang, L.X., Hattori, R., Aoyama, T., Yamamoto, Y., Doi, Y. 1994. Cloning and structural characterization of the human endothelial nitric- oxide-synthase gene. Eur. J. Biochem. 223: 719-726.
68. Montrucchio, G., Alloatti, G., and Camussi, G. 2000. Role of platelet-activating factor in cardiovascular pathophysiology. Physiol. Rev. 80: 1669-1699.
69. Morita, I., Schindler, M., Regier, M.K., Otto, J.C., Hori, T., DeWitt, D.L., and Smith, W.L. 1995. Different intracellular locations for prostaglandin endoperoxide H synthase-1 and -2. J. Biol. Chem. 270: 10902-10908.
70. + channels. Circ. Res. 87: 1149-1156.
71. 3 determines G-protein specificity. Nature 365: 166-170.
72. Narumiya, S. 1996. Prostanoid receptors and signal transduction. Prog. Brain Res. 113: 231-241.
73. Negishi, M., Sugimoto, Y., and Ichikawa, A. 1993. Prostanoid receptors and their biological actions. Prog. Lipid Res. 32: 417-434.
74. Northington, F.J., Tobin, J.R., Harris, A.P., Traystman, R.J., Koehler, R.C. 1997. Developmental and regional differences in nitric oxide synthase activity and blood flow in the sheep brain. J. Cereb. Blood. Flow Metab. 17: 109-115.
75. 2 inhibits the nuclear transcription of the human interleukin 2, but not the IL-4 gene in human T cells by targeting transcription factors AP-1 and NF-AT. Cell Immunol. 171: 95-101.
76. Paoletti, P., Chiabrando, C., Gaetani, P., Castelli, M.G., Butti, G., Martelli, L., and Rolli, M. 1989. Prostaglandins in human brain tumors. J. Neurosurg. Sci. 33: 65-69.
77. Parfenova, H., Eidson, T.H., and Leffler, C.W. 1997. Upregulation of COX-2 in cerebral microvascular endothelial cells by smooth muscle cell signals. Am. J. Physiol. 273: C277-C288.
78. Peralta, E.G., Ashkenazi, A., Winslow, J.W., Smith, D.H., Ramachandran, J., and Capon, D.J. 1987. Distinct primary structures, ligands binding properties and tissue-specifc expression of four human muscarinic acetylcholine receptors. EMBO J. 6: 3923-3929.
79. Peri, K., Hardy, P., Li, D.Y., Varma, D.R., and Chemtob, S. 1995. Prostaglandin G/H synthase-2 is a major contributor of brain prostaglandins in the newborn. J. Biol. Chem. 270: 24615-24620.
80. Pierce, K.L., Lutrell, L.M., and Lefkowitz, R.J. 2001. New mechanisms in heptahelical receptor signaling to mitogen activated protein kinase cascades. Oncogene 20: 1532-1539.
81. Pucci, M.L., Bao, YI, Chan, B., Itoh, S., Lu, R., Copeland, N.G., Gilbert, D.J., Jenkins, N.A., and Schuster, V.L. 1999. Cloning of mouse prostaglandin transporter PGT cDNA: species-specific substrate affinities. Am. J. Physiol. 277: R734-R741.
82. Robertson, R.P. 1986. Characterization and regulation of prostaglandin and leukotriene receptors: an overview. Prostaglandins 31: 395-411.
83. 2+ channels by G protein-coupled receptors. FASEB J. 2: 2784-2790.
84. sα in S49 lymphoma cells. Faseb J. 8: 252-258.
85. 2 to the nuclear envelope and endoplasmic reticulum. J. Biol. Chem. 270: 30749-30754.
86. Schmid, J.A., Birbach, A., Hofer-Warbinek, R., Pengg, M., Burner, U., Furtmüller, P.G., Binder, B.R., and de Martin, R. 2000. Dynamics of NFκB and IκBα studied with green fluorescent protein (GFP) fusion proteins. J. Biol. Chem. 275: 17035-17042.
87. Schuster, V.L. 1998. Molecular mechanisms of prostaglandin transport. Annu. Rev. Physiol. 60: 221-242.
88. Spencer, A.G., Woods, J.W., Arakawa, T., Singer, I.I., and Smith, W.L. 1998. Subcellular localization of prostaglandin endoperoxide H synthases-1 and -2 by immunoelectron microscopy. J. Biol. Chem. 273: 9886-9893.
89. Takei, Y., Takahashi, K., Kanaho, Y., and Katada, T. 1994. Possible involvement of a pertussis toxin-sensitive GTP-binding protein in protein transport into nuclei isolated from rat liver. J. Biochem. 115: 578-583.
90. Thompson, S., Mahadevan, L.C., and Clayton, A.L. 1999. MAP kinase-mediated signaling to nucleosomes and immediate-early gene induction. Cell Develop. Biol. 10: 205-214.
91. Topper, J.N., Cai, J., Stavrakis, G., Anderson, K.R., Woolf, E.A., Sampson, B.A., Schoen, F.J., Falb, D., Gimbrone, M.A., Jr. 1998. Human prostaglandin transporter gene (hPGT) is regulated by fluid mechanical stimuli in cultured ECs and expressed in vascular endothelium in vivo. Circulation 98: 2396-2403.
92. Turpin, P., Hay, R.T., and Dargemont, C. 1999. Characterization of IkappaBalpha nuclear import pathway. J. Biol. Chem. 274: 6804-6812.
93. 2. J. Biol. Chem. 276: 34918-34927.
94. Umayahara, Y., Ji, C., Centrella, M., Rotwein, P., and McCarthy, T.L. 1997. CCAAT/enhancer-binding protein δ activates insulin-like growth factor-1 gene transcription in osteoblasts. J. Biol. Chem. 272: 31793-31800.
95. Wickman, K., and Clapham, D.E. 1995. Ion channel regulation by G proteins. Physiol. Rev. 75: 865-885.
96. Yamamoto, S., Kawamura, K., and James, T.N. 1998. Intracellular distribution of adenylate cyclase in human cardiocytes determined by electron microscopic cytochemistry. Microscopy Res. Technique 40: 479-487.
97. Zhu, K., Baudhuin, L.M., Hong, G., Williams, F.S., Cristina, K.L., Kabarowski, J.H.S., Witte, O.W., and Xu, Y. 2001. Sphingosylphosphorylcholine and lysophosphatidylcholine are ligands for the G protein-coupled receptor GPR4. J. Biol. Chem. 276: 41325-41335.